The analysis demonstrated significantly higher expression levels of HSP90AA1 and P2RX7 (P < 0.001) and significantly lower expression levels of NLRP3 and NT5E (P < 0.001) in the brain tissues of patients with AD than in those of healthy controls. This evidence concerns the gene HSP90AA1 and Alzheimer disease.